These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9391102)

  • 21. The tumor suppressor protein Fhit. A novel interaction with tubulin.
    Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
    J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An FHIT tumor suppressor gene?
    Le Beau MM; Drabkin H; Glover TW; Gemmill R; Rassool FV; McKeithan TW; Smith DI
    Genes Chromosomes Cancer; 1998 Apr; 21(4):281-9. PubMed ID: 9559339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of the common fragile site FRA3B does not affect FHIT expression.
    Michael D; Rajewsky MF
    Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of FHIT in human cancer.
    Croce CM; Sozzi G; Huebner K
    J Clin Oncol; 1999 May; 17(5):1618-24. PubMed ID: 10334551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
    Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.
    Boldog F; Gemmill RM; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov MR; Klinger H; Drabkin HA
    Hum Mol Genet; 1997 Feb; 6(2):193-203. PubMed ID: 9063739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
    Huang K; Frey PA
    J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FHIT as tumor suppressor: mechanisms and therapeutic opportunities.
    Pekarsky Y; Palamarchuk A; Huebner K; Croce CM
    Cancer Biol Ther; 2002; 1(3):232-6. PubMed ID: 12432269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.
    Sevignani C; Calin GA; Cesari R; Sarti M; Ishii H; Yendamuri S; Vecchione A; Trapasso F; Croce CM
    Cancer Res; 2003 Mar; 63(6):1183-7. PubMed ID: 12649173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
    Shi Y; Zou M; Farid NR; Paterson MC
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):443-8. PubMed ID: 11085938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
    Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
    Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
    Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
    Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.
    Inoue H; Ishii H; Alder H; Snyder E; Druck T; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14584-9. PubMed ID: 9405656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel 'expressed sequence tags' within the FHIT gene locus in human chromosome region 3p14.2.
    Lux A; Bardenheuer W; Michael D; Bröcker F; Jülicher K; Vieten L; Michaelis S; Seeber S; Opalka B; Schütte J
    Hum Genet; 1997 Jul; 100(1):90-5. PubMed ID: 9225975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
    Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate.
    Murphy GA; Halliday D; McLennan AG
    Cancer Res; 2000 May; 60(9):2342-4. PubMed ID: 10811104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
    Pace HC; Garrison PN; Robinson AK; Barnes LD; Draganescu A; Rösler A; Blackburn GM; Siprashvili Z; Croce CM; Huebner K; Brenner C
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5484-9. PubMed ID: 9576908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.